David Domzalski, President and CEO at VYNE Therapeutics Inc. (VYNE), bought 150,000 shares at $1.38 ($207K) on 2020-09-08, disclosed to the SEC on 2020-09-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.38 | 75,000 | $103K | 50.0% |
| 2 | $1.38 | 75,000 | $104K | 50.0% |
| Total | $1.38 avg | 150,000 | $207K | 100% |
| Filing → |
| FOMX | SELL | 2018-12-06 | $275 | — | Filing → |
| FOMX | SELL | 2018-11-20 | $20K | — | Filing → |
| FOMX | SELL | 2018-11-13 | $9K | — | Filing → |